Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mycmed.2021.101122 http://scihub22266oqcxt.onion/10.1016/j.mycmed.2021.101122 33621792!7884920!33621792     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Mycol+Med 2021 ; 31 (2): 101122 Nephropedia Template TP {{tp|p=33621792|t=2021. Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort |pdf=|usr=}}{{33621792}} gab.com Text Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort JO: J Mycol Med http://www.kidney.de/pget.php?&tw=1&pmid=33621792 #FOAvip INTRODUCTION: Coronavirus disease 2019 or COVID-19 is a new infectious disease responsible for potentially severe respiratory impairment associated with initial immunosuppression. Similarly to influenza, several authors have described a higher risk of fungal infection after COVID-19, in particular for invasive pulmonary aspergillosis. The main objective here is to define the prevalence of invasive pulmonary aspergillosis (IPA) in a cohort of COVID-19 patients with moderate to severe acute respiratory disease syndrome (ARDS). MATERIAL AND METHODS: We conducted a large monocentric retrospective study investigating all the ventilated COVID-19 patients with ARDS hospitalized at Valenciennes' general hospital, France, between March 15, 2020 and April 30, 2020. In the center a systematic IPA screening strategy was carried out for all ARDS patients, with weekly tests of serum galactomannan and beta-D-glucan. Bronchoalveolar lavage with culture and chest CT scan were performed when the serum assays were positives. RESULTS: A total of 54 patients were studied. Their median age was 65 years, and 37 of the patients (71%) were male. Two patients had chronic immunosuppression and among all the patients, only 2 non-immunocompromised presented a putative IPA during their stay. CONCLUSION: The prevalence of IPA in this cohort of COVID-19 patients (3.7%) is not higher than what is described in the other ARDS populations in the literature. These results are however different from the previous publications on COVID-19 patients and must therefore be confirmed by larger and multicentric studies. Twit Text FOAVip Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort ????J Mycol Med http://www.kidney.de/pget.php?&tw=1&pmid=33621792 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33621792 #FOAvip English Wikipedia <ref>{{Cite pmid|33621792}}</ref> Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort #MMPMID33621792 Versyck M; Zarrougui W; Lambiotte F; Elbeki N; Saint-Leger P J Mycol Med 2021[Jun]; 31 (2): 101122 PMID33621792show ga INTRODUCTION: Coronavirus disease 2019 or COVID-19 is a new infectious disease responsible for potentially severe respiratory impairment associated with initial immunosuppression. Similarly to influenza, several authors have described a higher risk of fungal infection after COVID-19, in particular for invasive pulmonary aspergillosis. The main objective here is to define the prevalence of invasive pulmonary aspergillosis (IPA) in a cohort of COVID-19 patients with moderate to severe acute respiratory disease syndrome (ARDS). MATERIAL AND METHODS: We conducted a large monocentric retrospective study investigating all the ventilated COVID-19 patients with ARDS hospitalized at Valenciennes' general hospital, France, between March 15, 2020 and April 30, 2020. In the center a systematic IPA screening strategy was carried out for all ARDS patients, with weekly tests of serum galactomannan and beta-D-glucan. Bronchoalveolar lavage with culture and chest CT scan were performed when the serum assays were positives. RESULTS: A total of 54 patients were studied. Their median age was 65 years, and 37 of the patients (71%) were male. Two patients had chronic immunosuppression and among all the patients, only 2 non-immunocompromised presented a putative IPA during their stay. CONCLUSION: The prevalence of IPA in this cohort of COVID-19 patients (3.7%) is not higher than what is described in the other ARDS populations in the literature. These results are however different from the previous publications on COVID-19 patients and must therefore be confirmed by larger and multicentric studies. |*Critical Illness[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Biomarkers[MESH] |COVID-19/*complications[MESH] |Comorbidity[MESH] |Female[MESH] |France/epidemiology[MESH] |Galactose/analogs & derivatives[MESH] |Hospitals, General/statistics & numerical data[MESH] |Humans[MESH] |Immunocompromised Host[MESH] |Intensive Care Units/statistics & numerical data[MESH] |Invasive Pulmonary Aspergillosis/*complications/diagnosis[MESH] |Male[MESH] |Mannans/blood[MESH] |Middle Aged[MESH] |Opportunistic Infections/*complications[MESH] |Respiration, Artificial[MESH] |Respiratory Distress Syndrome/*etiology/therapy[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH]Invasive pulmonary aspergillosis in COVID-19 critically ill patients: (epmc).pdf DeepDyve Pubget Overpricing